Literature DB >> 3495884

Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation.

J C Reed, Y Tsujimoto, J D Alpers, C M Croce, P C Nowell.   

Abstract

The bcl-2 and c-myc proto-oncogenes are brought into juxtaposition with the immunoglobulin heavy chain locus in particular B-cell lymphomas, resulting in high levels of constitutive accumulation of their messenger RNAs. Precisely how the products of the bcl-2 and c-myc genes contribute to tumorigenesis is unknown, but observations that c-myc expression is rapidly induced in nonneoplastic lymphocytes upon stimulation of proliferation raise the possibility that this proto-oncogene is involved in the control of normal cellular growth. In addition to c-myc, the bcl-2 proto-oncogene also was expressed in normal human B and T lymphocytes after stimulation with appropriate mitogens. Comparison of the regulation of the expression of these proto-oncogenes demonstrated marked differences and provided evidence that, in contrast to c-myc, levels of bcl-2 messenger RNA are regulated primarily through transcriptional mechanisms.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495884     DOI: 10.1126/science.3495884

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  42 in total

Review 1.  The involvement of oncogenes and tumor suppressor genes in the control of apoptosis.

Authors:  M Oren
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

Review 2.  Transcriptional reprogramming during T helper cell differentiation.

Authors:  T M Aune
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

3.  Spontaneous increase of transforming growth factor beta production by bronchoalveolar mononuclear cells of patients with systemic autoimmune diseases affecting the lung.

Authors:  Y Deguchi
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

4.  MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2.

Authors:  K M Kozopas; T Yang; H L Buchan; P Zhou; R W Craig
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-15       Impact factor: 11.205

5.  Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies.

Authors:  G Packham; E L White; C M Eischen; H Yang; E Parganas; J N Ihle; D A Grillot; G P Zambetti; G Nuñez; J L Cleveland
Journal:  Genes Dev       Date:  1998-08-15       Impact factor: 11.361

6.  Expression of the bcl-2 protein in B cell lymphomas arising from mucosa associated lymphoid tissue.

Authors:  E Navratil; P Gaulard; P Kanavaros; J Audouin; J Bougaran; N Martin; J Diebold; D Y Mason
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

7.  bcl-2 protein in invasive ductal breast carcinomas.

Authors:  J Hurlimann; B Larrinaga; D L Vala
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

8.  Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis.

Authors:  B E Wilson; E Mochon; L M Boxer
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

9.  Ras activation of Erk restores impaired tonic BCR signaling and rescues immature B cell differentiation.

Authors:  Sarah L Rowland; Corinne L DePersis; Raul M Torres; Roberta Pelanda
Journal:  J Exp Med       Date:  2010-02-22       Impact factor: 14.307

10.  Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease.

Authors:  A Strasser; S Whittingham; D L Vaux; M L Bath; J M Adams; S Cory; A W Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.